External Validation of the ASSURE Model for Predicting Oncological Outcomes After Resection of High-risk Renal Cell Carcinoma (RESCUE Study: UroCCR 88)

A prognostic model based on the population of the ASSURE phase 3 trial has recently been described. The ASSURE model stratifies patients into risk groups to predict survival after surgical resection of intermediate- and high-risk localised kidney cancer. We evaluated this model in an independent coh...

Descripción completa

Detalles Bibliográficos
Autores principales: Khene, Zine-Eddine, Larcher, Alessandro, Bernhard, Jean-Christophe, Doumerc, Nicolas, Ouzaid, Idir, Capitanio, Umberto, Nouhaud, François-Xavier, Boissier, Romain, Rioux-Leclercq, Nathalie, De La Taille, Alexandre, Barthelemy, Philippe, Montorsi, Francesco, Rouprêt, Morgan, Bigot, Pierre, Bensalah, Karim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Brief Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502703/
https://www.ncbi.nlm.nih.gov/pubmed/34661173
http://dx.doi.org/10.1016/j.euros.2021.09.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502703/
https://www.ncbi.nlm.nih.gov/pubmed/34661173
http://dx.doi.org/10.1016/j.euros.2021.09.004

Ejemplares similares